Erick Wayne DeVinney Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Erick Wayne DeVinney.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Erick Wayne DeVinney. Erick Wayne DeVinney is VP of Clin. & Trans. Sciences in Axogen, Inc. ($LECT) and VP, Clinical&Translational Sc in AxoGen, Inc. ($LECT).
Latest Insider Trading Transactions of Erick Wayne DeVinney
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Option Exercise | M | 2.86 | 10,000 | 28,600 | 0 | |
| Apr 30 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Buy | M | 2.86 | 10,000 | 28,600 | 78,082 | 68.1 K to 78.1 K (+14.69 %) |
| Mar 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
| Mar 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
| Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 18.70 | 322 | 6,021 | 68,082 | 68.4 K to 68.1 K (-0.47 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,181 | 0 | 68,404 | 67.2 K to 68.4 K (+1.76 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 18.70 | 1,542 | 28,835 | 67,223 | 68.8 K to 67.2 K (-2.24 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,050 | 0 | 68,765 | 63.7 K to 68.8 K (+7.93 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 17.81 | 371 | 6,608 | 63,240 | 63.6 K to 63.2 K (-0.58 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,500 | 0 | 63,611 | 62.1 K to 63.6 K (+2.42 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 16.42 | 147 | 2,414 | 62,111 | 62.3 K to 62.1 K (-0.24 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 575 | 0 | 62,258 | 61.7 K to 62.3 K (+0.93 %) |
| Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 4.81 | 15,000 | 72,150 | 0 | |
| Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 16.50 | 4,373 | 72,155 | 61,683 | 66.1 K to 61.7 K (-6.62 %) |
| Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 4.81 | 15,000 | 72,150 | 66,056 | 51.1 K to 66.1 K (+29.38 %) |
| Apr 29 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 0.27 | 2,530 | 683 | 0 | |
| Apr 29 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 0.27 | 2,530 | 683 | 51,056 | 48.5 K to 51.1 K (+5.21 %) |
| Mar 18 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Mar 18 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
| Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 14.68 | 351 | 5,153 | 48,526 | 48.9 K to 48.5 K (-0.72 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,181 | 0 | 48,877 | 47.7 K to 48.9 K (+2.48 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 14.68 | 1,498 | 21,991 | 47,696 | 49.2 K to 47.7 K (-3.05 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,049 | 0 | 49,194 | 44.1 K to 49.2 K (+11.44 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 16.73 | 281 | 4,701 | 42,840 | 43.1 K to 42.8 K (-0.65 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,150 | 0 | 43,121 | 42 K to 43.1 K (+2.74 %) |
| Feb 19 2019 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 17.57 | 1,498 | 26,320 | 41,971 | 43.5 K to 42 K (-3.45 %) |
| Feb 19 2019 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,079 | 0 | 43,469 | 38.4 K to 43.5 K (+13.23 %) |
| Dec 31 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
| Dec 31 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 19.17 | 11,900 | 228,123 | 11,900 | |
| Nov 15 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 0.27 | 274 | 74 | 0 | |
| Nov 15 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 2.74 | 35,000 | 95,900 | 0 | |
| Nov 15 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 0.27 | 274 | 74 | 37,410 | 37.1 K to 37.4 K (+0.74 %) |
| Nov 15 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 33.28 | 2,882 | 95,913 | 37,136 | 40 K to 37.1 K (-7.20 %) |
| Nov 15 2018 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 2.74 | 35,000 | 95,900 | 40,018 | 5 K to 40 K (+697.49 %) |
| Dec 20 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
| Dec 20 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 27.00 | 13,900 | 375,300 | 13,900 | |
| Mar 14 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 0.27 | 359 | 97 | 0 | |
| Mar 14 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 0.27 | 4,659 | 1,258 | 0 | |
| Mar 14 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 0.27 | 359 | 97 | 5,018 | 4.7 K to 5 K (+7.71 %) |
| Mar 14 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 0.27 | 4,659 | 1,258 | 4,659 | 0 to 4.7 K |
| Jan 03 2017 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 8.95 | 50,000 | 447,500 | 50,000 | |
| Dec 30 2015 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 5.09 | 20,000 | 101,800 | 20,000 |
Page: 1